Skip to content
OpenCapital
Get started

Ionis Pharmaceuticals IONS Available For Sale Securities Debt Securities Current

Available For Sale Securities Debt Securities Current at other companies

Pfizer logo
PfizerPFE
——
ALN
Alnylam PharmaceuticalsALNY
——
BridgeBio Pharma logo
BridgeBio PharmaBBIO
——
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
——
Royalty Pharma logo
Royalty PharmaRPRX
——
Viatris logo
ViatrisVTRS
——

Other financials

Income statement

See full
Revenue$246.1M+87.0%
Gross profit$243.1M+86.8%
Operating income-$117.4M+20.0%
Net income-$92.5M+37.0%
EPS (diluted)-$0.56+39.8%

Balance sheet

See full
Cash & equivalents$173.4M-34.4%
Total debt$691.7M+334%
Total equity$491.4M+3.3%
Total assets$3.4B+22.6%

Cash flow

See full
Operating cash flow-$792.8M-426%
CapEx$21.8M+73.0%
Free cash flow-$814.6M-399%

Valuation

See full
Market cap$12.25B+159%
Enterprise value$12.77B+175%
P/S11.6×+5.0×

Profitability

See full
Gross margin98.4%-0.2pp
Operating margin-33.3%-11.0pp
Net margin-30.9%-10.5pp
FCF margin-77.4%+35.3pp

Returns & leverage

See full
Return on equity-67.6%-20.3pp
Debt / equity1.4×+1.1×
Current ratio4.1×-5.6×

Where this comes from

Reported directly by Ionis Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ionis Pharmaceuticals's available for sale securities debt securities current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ionis Pharmaceuticals's available for sale securities debt securities current?
Ionis Pharmaceuticals (IONS) reported available for sale securities debt securities current of $1.12B in Q1 2026.
How has Ionis Pharmaceuticals's available for sale securities debt securities current changed year-over-year?
Ionis Pharmaceuticals's available for sale securities debt securities current decreased by 9.4% year-over-year, from $1.23B to $1.12B.
What is the long-term trend for Ionis Pharmaceuticals's available for sale securities debt securities current?
Over 5 years (2020 to 2025), Ionis Pharmaceuticals's available for sale securities debt securities current has grown at a 1.1% compound annual growth rate (CAGR), from $1.49B to $1.58B.